Zhen Su - 31 Aug 2023 Form 4 Insider Report for Karyopharm Therapeutics Inc. (KPTI)

Role
Director
Signature
/s/Nancy Smith as Attorney-in-Fact for Zhen Su
Issuer symbol
KPTI
Transactions as of
31 Aug 2023
Net transactions value
$0
Form type
4
Filing time
01 Sep 2023, 08:20:11 UTC
Next filing
22 Mar 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KPTI Nonstatutory Stock Option (right to buy) Award $0 +68,000 $0.000000 68,000 31 Aug 2023 Common Stock 68,000 $1.28 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on August 31, 2023. The shares underlying the option vest as to one-third (1/3) of the shares on August 31, 2024 and as to the remaining two-thirds (2/3) of the shares in 24 equal monthly installments thereafter.